Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ariad Pharmaceuticals
Ariad Pharmaceuticals
Ariad advances cancer drug, nabs $25M from partner Merck
Bizjournals.com
Thu, 08/18/11 - 05:35 pm
Ariad Pharmaceuticals
Merck
sarcoma
ridaforolimus
ARIAD shares rise on EU review of potential cancer drug
Bizjournals.com
Mon, 08/1/11 - 12:09 pm
Ariad Pharmaceuticals
EU
Merck
ridaforolimus
4 Biotech Companies Reporting Earnings Next Week With Recent Winning Streaks
Seeking Alpha
Sat, 07/30/11 - 09:46 am
Ariad Pharmaceuticals
NPS Pharmaceuticals
Immunogen
Alnylam
These 2 Biotechs Are Dangerous Investments
Motley Fool
Sat, 07/23/11 - 03:16 pm
Pharmasset
Ariad Pharmaceuticals
More Hot Biotech Trades for Second Half 2011
TheStreet.com
Tue, 07/12/11 - 10:27 am
Targacept
Aveo Pharmaceutical
Threshold Pharmaceuticals
Raptor Pharmaceuticals
Vertex Pharmaceuticals
Soligenix
Spectrum Pharmaceuticals
NuPathe
Pharmasset
Incyte
Adventrx
Celsion
Alimera
GTx
Ariad Pharmaceuticals
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
biotech
Gilead Sciences
Dendreon
PDL Biopharma
Cell Therapeutics
Amgen
Aeterna Zentaris
Xoma
Geron
Orexigen
Zalicus
Spectrum Pharmaceuticals
Ariad Pharmaceuticals
Biogen Idec
Momenta
StemCells
Ariad-Merck Cancer Medicine Extends Patients’ Lives in Study
Bloomberg
Mon, 06/6/11 - 09:24 am
Ariad Pharmaceuticals
Merck
ridaforolimus
Big-Pharma Drugs to Dominate Cancer Event
Barron's
Fri, 06/3/11 - 06:48 pm
ASCO
cancer
Pfizer
Roche
Bristol-Myers Squibb
Eli Lilly
Merck
Ariad Pharmaceuticals
Novartis
ASCO: Cancer Stock Winners, Losers
TheStreet.com
Thu, 05/19/11 - 01:56 pm
ASCO
Vical
Oxigene
Agenus
Ariad Pharmaceuticals
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thu, 05/12/11 - 11:48 am
Ariad Pharmaceuticals
Exelixis
ridaforolimus
cancer
cabozantinib
Ariad Pharma books bigger 1Q loss on charge
Yahoo/AP
Wed, 05/4/11 - 08:46 pm
Ariad Pharmaceuticals
earnings
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
3 Biotech Stocks on Our ASCO Watchlist
Seeking Alpha
Mon, 03/28/11 - 09:49 am
ASCO
Array Biopharma
Spectrum Pharmaceuticals
Ariad Pharmaceuticals
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Ariad Pharmaceuticals: Solid Company but Not a Steal
Seeking Alpha
Mon, 03/21/11 - 11:24 am
Ariad Pharmaceuticals
Genie About to Come Out of Ariad's Bottle
Seeking Alpha
Mon, 01/24/11 - 11:37 am
Ariad Pharmaceuticals
Merck
Novartis
Ariad Gains Most in 18 Months on Cancer Drug Results
Bloomberg
Wed, 01/19/11 - 09:07 am
sarcoma
Ariad Pharmaceuticals
ridaforolimus
Ariad Sarcoma Drug Delays Progression
TheStreet.com
Tue, 01/18/11 - 10:47 am
Ariad Pharmaceuticals
sarcoma
ridaforolimus
Biotech 2011 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/5/11 - 11:09 am
biotech
Celgene
Dendreon
MannKind
Vertex Pharmaceuticals
Genzyme
Ariad Pharmaceuticals
Keryx
Biotech's Brighter Corners
TheStreet.com
Wed, 12/8/10 - 02:15 pm
Neurocrine
Ariad Pharmaceuticals
Oncolytics
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »